Luciano Adorini Selected Research

Luciano Adorini Research Topics

Disease

22	Inflammation (Inflammations) 12/2019 - 12/2002
14	Autoimmune Diseases (Autoimmune Disease) 05/2009 - 01/2002
13	Fibrosis (Cirrhosis) 01/2020 - 12/2009
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2011 - 05/2002
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2011
6	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2012 - 06/2006
5	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 06/2009
5	Insulin Resistance 12/2019 - 01/2013
5	Non-alcoholic Fatty Liver Disease 01/2019 - 04/2013
5	Atherosclerosis 10/2018 - 08/2011
5	Proteinuria 01/2018 - 12/2009
5	Prostatitis 09/2009 - 12/2006
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2010
4	Obesity 01/2018 - 12/2009
4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2014 - 07/2012
4	Hypercalcemia (Milk Alkali Syndrome) 06/2010 - 05/2004
3	Reperfusion Injury 04/2022 - 01/2018
3	Dyslipidemias (Dyslipidemia) 01/2020 - 08/2011
3	Disease Progression 01/2018 - 05/2002
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 11/2010
3	Hypoxia (Hypoxemia) 01/2017 - 01/2012
3	Hyperglycemia 08/2011 - 11/2010
3	Neoplasms (Cancer) 11/2008 - 01/2006
2	Metabolic Diseases (Metabolic Disease) 06/2022 - 10/2010
2	Fatty Liver 06/2022 - 11/2018
2	Liver Diseases (Liver Disease) 06/2022 - 10/2010
2	Ischemia 04/2022 - 01/2018
2	Hypercholesterolemia 01/2018 - 01/2018
2	Kidney Diseases (Kidney Disease) 01/2017 - 01/2016
2	Glucose Intolerance 01/2014 - 01/2011
2	Colitis 04/2011 - 06/2010
2	Rheumatoid Arthritis 01/2011 - 11/2004
2	Breast Neoplasms (Breast Cancer) 11/2008 - 03/2007
2	Carcinogenesis 11/2008 - 03/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2007 - 06/2002
2	Prostatic Neoplasms (Prostate Cancer) 03/2007 - 06/2006
2	Pelvic Pain 02/2007 - 12/2006
2	Hyperplasia 07/2005 - 02/2005
1	Alcoholic Fatty Liver 06/2022
1	Cholestasis 11/2021
1	Intrahepatic Cholestasis of Pregnancy 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Hepatomegaly 12/2019

Drug/Important Bio-Agent (IBA)

18	obeticholic acidIBA 04/2022 - 11/2010
14	Calcitriol Receptors (Calcitriol Receptor)IBA 06/2010 - 06/2002
12	Bile Acids and Salts (Bile Acids)IBA 06/2022 - 10/2010
10	6-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA 01/2020 - 10/2010
9	LipidsIBA 12/2019 - 12/2009
9	Insulin (Novolin)FDA Link 01/2018 - 01/2002
8	LigandsIBA 06/2022 - 06/2002
7	6alpha-ethyl-23(S)-methylcholic acidIBA 06/2022 - 10/2011
7	BXL628IBA 04/2009 - 02/2005
6	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2011
6	Messenger RNA (mRNA)IBA 01/2019 - 10/2002
5	AcidsIBA 11/2018 - 12/2009
5	Interleukin-6 (Interleukin 6)IBA 01/2017 - 04/2009
5	Vitamin D FDA LinkGeneric 01/2011 - 08/2004
5	Calcitriol (Calcijex)FDA LinkGeneric 07/2007 - 10/2002
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2022 - 10/2010
4	EnzymesIBA 11/2021 - 11/2010
4	Hormones (Hormone)IBA 11/2017 - 04/2002
4	CytokinesIBA 01/2017 - 02/2007
4	Testosterone (Sustanon)FDA Link 10/2012 - 01/2012
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2010 - 06/2006
4	1,25-dihydroxyvitamin DIBA 06/2010 - 04/2002
4	Interleukin-12 (IL 12)IBA 09/2009 - 05/2002
3	Pharmaceutical PreparationsIBA 12/2019 - 01/2006
3	Streptozocin (Streptozotocin)FDA Link 01/2018 - 11/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 12/2009
3	AndrogensIBA 07/2012 - 02/2005
3	Interleukin-8 (Interleukin 8)IBA 01/2012 - 02/2007
3	AutoantigensIBA 09/2009 - 05/2002
3	rho-Associated KinasesIBA 04/2009 - 02/2007
3	Peptides (Polypeptides)IBA 08/2007 - 05/2003
3	ChemokinesIBA 02/2007 - 12/2002
2	Matrix Metalloproteinases (MMPs)IBA 04/2022 - 01/2020
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 10/2010
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 02/2005
2	Cholic AcidIBA 10/2018 - 07/2014
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2018 - 04/2015
2	MonocrotalineIBA 11/2017 - 01/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2017 - 01/2017
2	SteroidsIBA 11/2017 - 12/2006
2	Alanine Transaminase (SGPT)IBA 04/2015 - 09/2013
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2014 - 10/2012
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2011 - 10/2010
2	Dextrans (Dextran)FDA Link 04/2011 - 06/2010
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2011 - 06/2010
2	NF-kappa B (NF-kB)IBA 04/2009 - 08/2004
2	Cholecalciferol (Vitamin D3)FDA Link 11/2008 - 01/2006
2	AntigensIBA 08/2005 - 11/2004
1	1- (4- (3- (hydroxyimino)- 3- (2- methylpyridin- 4- yl)- 1- o- tolylpropyl)phenyl)piperidine- 4- carboxylic acidIBA 06/2022
1	Progesterone FDA LinkGeneric 11/2021
1	Antifibrotic AgentsIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	Galectin 3 (LGALS3)IBA 12/2019
1	Hematoxylin (Haematoxylon)IBA 12/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2019
1	Liraglutide FDA Link 12/2019

Therapy/Procedure

5	Therapeutics 06/2022 - 02/2005